Citigroup’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,800
Closed -$1.51M 7786
2020
Q3
$1.51M Buy
+10,800
New +$1.32M ﹤0.01% 2915
2020
Q1
Sell
-28,100
Closed -$704K 7885
2019
Q4
$704K Buy
+28,100
New +$672K ﹤0.01% 4107

Citigroup's LVGO Position: Q4 2020 in Review

Citigroup sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 263,871 shares — an estimated $37M sold.

Citigroup first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $37M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Citigroup reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Citigroup sold 263,871 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $37M.
  • Citigroup first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • Citigroup's Livongo Health, Inc. Common Stock position peaked at $37M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Citigroup's 13F filing for Q4 2020, filed 11 Feb 2021.